On Oct. 28, the Food and Drug Administration (FDA) approved the Amplatzer PFO Occluder device, which reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot passing through a patent foramen ovale and then travelling to the brain. Read more
FDA approves device for preventing recurrent strokes in some patients
The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.